Compare ZBH & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | DECK |
|---|---|---|
| Founded | 1927 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9B | 12.4B |
| IPO Year | N/A | 1993 |
| Metric | ZBH | DECK |
|---|---|---|
| Price | $94.41 | $99.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 21 |
| Target Price | $108.56 | ★ $121.63 |
| AVG Volume (30 Days) | 2.1M | ★ 3.5M |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ 18.83 |
| EPS | 4.03 | ★ 6.75 |
| Revenue | ★ $8,010,900,000.00 | $5,244,323,000.00 |
| Revenue This Year | $8.20 | $9.84 |
| Revenue Next Year | $5.92 | $7.36 |
| P/E Ratio | $23.38 | ★ $14.77 |
| Revenue Growth | 5.47 | ★ 12.62 |
| 52 Week Low | $85.33 | $78.91 |
| 52 Week High | $114.44 | $223.98 |
| Indicator | ZBH | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 67.87 |
| Support Level | $92.14 | $81.40 |
| Resistance Level | $98.34 | $86.09 |
| Average True Range (ATR) | 1.99 | 3.00 |
| MACD | 0.49 | 2.31 |
| Stochastic Oscillator | 58.27 | 99.97 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has nearly 200 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.